Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2464854014 | Epidermal growth factor receptor inhibitor (product) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 2471189014 | Epidermal growth factor receptor inhibitor | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 2477411017 | EGFR inhibitor | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT core module |
| 3646769018 | Product containing epidermal growth factor receptor antagonist | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3646770017 | Epidermal growth factor receptor antagonist product | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3646771018 | Product containing epidermal growth factor receptor antagonist (product) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3647021016 | EGFR inhibitor product | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT core module |
| 3746231014 | Epidermal growth factor receptor antagonist-containing product | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 4541185012 | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 4541186013 | Epidermal growth factor receptor antagonist antineoplastic agent | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 108356601000001115 | Epidermal growth factor receptor inhibitor | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Is a | Medicinal product acting as antineoplastic agent (product) | true | Inferred relationship | Existential restriction modifier | ||
| Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Has active ingredient | Substance with epidermal growth factor receptor inhibitor mechanism of action (substance) | true | Inferred relationship | Existential restriction modifier | 1 | |
| Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Is a | Medicinal product categorized by disposition | false | Inferred relationship | Existential restriction modifier | ||
| Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Is a | Product containing enzyme inhibitor | false | Inferred relationship | Existential restriction modifier | ||
| Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Is a | Product containing protein kinase inhibitor | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing cetuximab | Is a | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing protein-tyrosine kinase inhibitor | Is a | False | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing panitumumab | Is a | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing osimertinib (medicinal product) | Is a | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing necitumumab (medicinal product) | Is a | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing gefitinib | Is a | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing erlotinib | Is a | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing vandetanib | Is a | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing lapatinib | Is a | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing trastuzumab deruxtecan (medicinal product) | Is a | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing trastuzumab | Is a | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing pertuzumab | Is a | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing trastuzumab emtansine (medicinal product) | Is a | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing margetuximab (medicinal product) | Is a | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier | |
| Product containing amivantamab (medicinal product) | Is a | True | Medicinal product containing epidermal growth factor receptor antagonist and acting as antineoplastic agent (product) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR